_________
false
C002
ביוליין אר אקס בע"מ
2
Public
BIOLINE RX LTD
8702
Corporation no:
513398750
Stock Exchange/Market:
ביוליין אר אקס
2271
380
הרטום
19
,
ירושלים
91450
,
,
Tel:
02-5489100
,
02-5489116
Fax:
02-5489101
E.mail address:
info@BioLineRx.com
Date of transmission:
13/09/2011
Time of broadcast:
08:46
08:27:33
Reference:
2011-02-272376
Israel Securities Authority
Tel Aviv Stock Exchange
www.isa.gov.il
www.tase.co.il
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
BioLineRx Announces Positive Preliminary Results from Phase I Clinical Trial of BL-1021 for Neuropathic Pain.
6K_BL1021_isa.pdf
For a non-binding convenience translation into Hebrew of the attached report, please see the Company’s website.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure:
04/09/2011
Name of the Signatory:
:
Peleg Leeat
,
Position of Signatory in the reporting corporation:
General Counsel
,
Name of Employer Company:
.
Hartum St
Telephone:
02-5489100
,
Facsimile:
02-5489101
,
E-mail:
leeatp@biolinerx.com
2